Reversal of Pre-injury Factor-Xa Inhibitors with Prothrombin Complex Concentrates in Patients Following Traumatic Brain Injury
出版年份 2023 全文链接
标题
Reversal of Pre-injury Factor-Xa Inhibitors with Prothrombin Complex Concentrates in Patients Following Traumatic Brain Injury
作者
关键词
-
出版物
CLINICAL NEUROLOGY AND NEUROSURGERY
Volume -, Issue -, Pages 108040
出版商
Elsevier BV
发表日期
2023-11-04
DOI
10.1016/j.clineuro.2023.108040
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Clinical Relevance of Preclinical and Clinical Studies of Four-Factor Prothrombin Complex Concentrate for Treatment of Bleeding Related to Direct Oral Anticoagulants
- (2023) Ravi Sarode et al. ANNALS OF EMERGENCY MEDICINE
- Four-factor prothrombin complex concentrate for the treatment of oral factor Xa inhibitor-associated bleeding: a meta-analysis of fixed versus variable dosing
- (2023) Thita Chiasakul et al. Research and Practice in Thrombosis and Haemostasis
- Andexanet alfa versus four-factor prothrombin complex concentrate for the reversal of apixaban- or rivaroxaban-associated intracranial hemorrhages
- (2022) Haithuy Pham et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Impact of Factor Xa Inhibitor Reversal with Prothrombin Complex Concentrate in Patients with Traumatic Brain Injuries
- (2022) Grace E. Cooksey et al. Neurocritical Care
- Evaluation of Direct Oral Anticoagulant Reversal Agents in Intracranial Hemorrhage
- (2022) Rahul Chaudhary et al. JAMA Network Open
- Andexanet Alfa or Prothrombin Complex Concentrate for Factor Xa Inhibitor Reversal in Acute Major Bleeding
- (2021) Charlie J. Nederpelt et al. CRITICAL CARE MEDICINE
- Low‐dose versus standard‐dose four‐factor prothrombin complex concentrate for factor‐Xa inhibitor reversal in spontaneous and traumatic intracranial hemorrhage
- (2021) Ava E. Cascone et al. PHARMACOTHERAPY
- Availability of Specific Direct Oral Anticoagulant Reversal Agents in US Hospitals
- (2021) Zahir Kanjee et al. JAMA Network Open
- Meta-Analysis of Reversal Agents for Severe Bleeding Associated With Direct Oral Anticoagulants
- (2021) Antonio Gómez-Outes et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Eastern Association for the Surgery of Trauma Multicenter Trial: Comparison of pre-injury antithrombotic use and reversal strategies among severe traumatic brain injury patients
- (2021) Brian K. Yorkgitis et al. Journal of Trauma and Acute Care Surgery
- A review of guidelines on anticoagulation reversal across different clinical scenarios – Is there a general consensus?
- (2020) Truman J. Milling et al. AMERICAN JOURNAL OF EMERGENCY MEDICINE
- Factor Xa Inhibitor-Related Intracranial Hemorrhage
- (2020) Nicholas G. Panos et al. CIRCULATION
- Efficacy of 4-Factor Prothrombin Complex Concentrates in Factor Xa Inhibitor-Associated Intracranial Bleeding
- (2020) Matthew J. Korobey et al. Neurocritical Care
- Comparison of Low- Versus High-Dose Four-Factor Prothrombin Complex Concentrate (4F-PCC) for Factor Xa Inhibitor–Associated Bleeding: A Retrospective Study
- (2020) H Andrew Wilsey et al. JOURNAL OF INTENSIVE CARE MEDICINE
- 2020 ACC Expert Consensus Decision Pathway on Management of Bleeding in Patients on Oral Anticoagulants
- (2020) Gordon F. Tomaselli et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Full Study Report of Andexanet Alfa for Bleeding Associated with Factor Xa Inhibitors
- (2019) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
- Efficacy and safety of prothrombin complex concentrate for vitamin K antagonist-associated intracranial hemorrhage: a systematic review and meta-analysis
- (2019) Rui Pan et al. NEUROLOGICAL SCIENCES
- Reversal of Direct Oral Anticoagulants: Guidance from the Anticoagulation Forum
- (2019) Adam Cuker et al. AMERICAN JOURNAL OF HEMATOLOGY
- Safety, efficacy, and cost of four-factor prothrombin complex concentrate (4F-PCC) in patients with factor Xa inhibitor-related bleeding: a retrospective study
- (2019) Melanie N. Smith et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- A Low-Dose 4F-PCC Protocol for DOAC-Associated Intracranial Hemorrhage
- (2019) Karen Berger et al. JOURNAL OF INTENSIVE CARE MEDICINE
- Cost comparison of andexanet versus prothrombin complex concentrates for direct factor Xa inhibitor reversal after hemorrhage
- (2019) Jennifer A. Frontera et al. JOURNAL OF THROMBOSIS AND THROMBOLYSIS
- Effect of low and moderate dose FEIBA to reverse major bleeding in patients on direct oral anticoagulants
- (2018) W.E. Dager et al. THROMBOSIS RESEARCH
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Comparative effectiveness and safety of non-vitamin K antagonist oral anticoagulants and warfarin in patients with atrial fibrillation: propensity weighted nationwide cohort study
- (2016) Torben Bjerregaard Larsen et al. BMJ-British Medical Journal
- Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
- (2016) Xiaoxi Yao et al. Journal of the American Heart Association
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started